Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Revolutionizing vascular grafting with a durable solution

Our next guest is a multi-technology biomedical company, focused on the development and commercialization of medical technologies. Marizyme Inc. (OTCQB:MRZM) has had its sights set on development of medical technology and products, one of which is DuraGraft. J...
Brieanna McCutcheon | September 27, 2023 |

Edwards Lifesciences Gets a Charge on Positive Q2 Earnings Report

Edwards Lifesciences is trading higher after reporting higher than expected adjusted earnings for Q2/19. The company estimates that the FDA will approve its SAPIEN 3 valve and SAPIEN 3 Ultra system in Q3/19. Structural heart disease and critical care monitor...
Streetwise Reports | July 25, 2019 |

Neovasc Shares Climb 80% Upon FDA Premarket Approval Filing for Refractory Angina Device

Shares of specialty cardiovascular medical device company Neovasc Inc. opened more than 100% higher after the firm reported that it submitted a Premarket Approval application to the FDA for its Neovasc Reducer device for use in the treatment of refractory angina. This...
Streetwise Reports | January 3, 2020 |

Buzz on the Bullboards: Staying healthy

From short-term health care bets to long-term energy plays, and the swings of the cannabis market, small-cap investors have had their hands full keeping up with the markets in 2023. A recent merger among top names in cannabis hit the health care market hard this...
Jonathon Brown | April 13, 2023 |

The Medical Device Co. That’s on the Cutting-Edge of Advancing Heart Disease Treatment

Back in early September , we introduced our Stockhouse audience to a unique play in the emerging medical tech space – Neovasc Inc. ( TSX: NVCN , OTCQB: NVCN , Forum ). The company develops, manufactures, and markets products for the rapidly growing cardiovascular marke...
Dave Jackson | November 29, 2021 |

The future of the textile marketplace

Countries manufacturing textiles will likely acquire a healthy dose of revenue into their economy. According to fiber2fashion.com , the population is increasing to 9.5 billion, with the global apparel market reaching over $2 trillion by 2025. Given the massive gr...
Brieanna McCutcheon | April 28, 2023 |

SunPower (SPWRA): Retreating into familiar territory

Last week, SunPower Corporation ( NASDAQ: SPWRA , Stock Forum ) updated its 2011 guidance, predicting that ex-items earnings per share would range between $1.75 and $2.05. Revenue for the upcoming fiscal year is predicted to arrive between $2.65 billion and $2.85 billion....
Andrea Kramer | October 28, 2012 |

Tracking The Stock Market's Progress Versus Historical Cases

STUDY UPDATE A March 1 analysis covered historical cases similar to the 2019 setup shown below, where the S&P 500’s 100-day moving average (blue) dropped below a flattish-to-down 200-day (red). Stocks rallied and the market closed above the 200-day for el...
Chris Ciovacco | April 9, 2019 |

Nov 23rd 2019, Crypto Chartbook – Why markets work

Why markets work We as humans are fooled by a brain that functions on comparison. However, based on the true principle, every moment is unique and we expand with every time increment into an absolutely new future (big bang theory). We would be overwhelmed by the vastness o...
Korbinian Koller | November 26, 2019 |

Feb 7th 2020, Crypto Chartbook – The trend is your friend

The trend is your friend That might be an overused term but it is so very true! After “compound interest” (Albert Einstein: “Compound interest is the 8th wonder of the world”), a directional market is the strongest free e...
Korbinian Koller | February 10, 2020 |
1 2 3 4 5 6 7 8 9 10 ...